Walleye Capital LLC Karyopharm Therapeutics Inc. Transaction History

Walleye Capital LLC

$38.9 Billion
Q4 2024

A detailed history of Walleye Capital LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 10,451 shares of KPTI stock, worth $6,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,451

Holding current value

$6,270

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.6 - $0.99 $6,270 - $10,346	10,451 New	10,451 $7,000
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $293,675 - $405,355	-103,407 Reduced 64.59%	56,700 $220,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $1.27 Million - $3.05 Million	-513,565 Reduced 76.23%	160,107 $544,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $4.37 Million - $6.24 Million	-1,071,743 Reduced 61.4%	673,672 $3.68 Million
Q2 2022 Aug 08, 2022	BUY	$4.15 - $8.37 $6.9 Million - $13.9 Million	1,662,337 Added 2000.94%	1,745,415 $7.87 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $408,824 - $994,736	69,175 Added 497.55%	83,078 $612,000
Q4 2021 Mar 03, 2022	BUY	$5.21 - $8.61 $72,434 - $119,704	13,903 New	13,903 $89,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $352,584 - $536,310	-21,240 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $757,912 - $1.46 Million	-52,706 Reduced 71.28%	21,240 $408,000
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $682,521 - $1.45 Million	73,946 New	73,946 $1.42 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

59.6M

Call Options Held

547K

Put Options Held

67K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.59 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

6.32M
Shares

$3.79 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

4.91M
Shares

$2.94 Million
0.53% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.5 Million
0.0% of portfolio
Morgan Stanley New York, NY

3.51M
Shares

$2.11 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $47.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account